Stroke Research and Biomarkers

Biomarkers circulating in the bloodstream may serve as a predictive window for recurrent stroke risk and also help doctors accurately assess what is happening in the brains of patients with acute traumatic brain injury (TBI). Researchers at Emory University School of Medicine, led by Michael Frankel, MD, Emory professor of neurology and director of Grady Hospital's Marcus Stroke & Neuroscience Center, are studying biomarkers as part of two ancillary studies of blood samples using two grants from the National Institutes of Health.